ResMed Inc.
RMD
$245.73
-$13.29-5.13%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.53% | -0.92% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.53% | -0.92% | |||
| Cost of Revenue | 5.79% | -2.24% | |||
| Gross Profit | 6.99% | -0.10% | |||
| SG&A Expenses | 6.37% | -2.24% | |||
| Depreciation & Amortization | -1.04% | -7.13% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.64% | -2.04% | |||
| Operating Income | 8.21% | 1.27% | |||
| Income Before Tax | 11.05% | -2.46% | |||
| Income Tax Expenses | 5.39% | 25.41% | |||
| Earnings from Continuing Operations | 12.64% | -8.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 12.64% | -8.21% | |||
| EBIT | 8.21% | 1.27% | |||
| EBITDA | 7.97% | -1.99% | |||
| EPS Basic | 12.90% | -8.02% | |||
| Normalized Basic EPS | 7.86% | 1.53% | |||
| EPS Diluted | 13.08% | -8.18% | |||
| Normalized Diluted EPS | 8.00% | 1.43% | |||
| Average Basic Shares Outstanding | -0.23% | -0.20% | |||
| Average Diluted Shares Outstanding | -0.36% | -0.09% | |||
| Dividend Per Share | 0.00% | 13.21% | |||
| Payout Ratio | -0.11% | 0.23% | |||